Definitive Healthcare Corp. (DH)
NASDAQ: DH · Real-Time Price · USD
3.810
+0.020 (0.53%)
Jun 27, 2025, 4:00 PM - Market closed
Definitive Healthcare Stock Forecast
Stock Price Forecast
According to 9 professional analysts, the 12-month price target for Definitive Healthcare stock ranges from a low of $3.00 to a high of $7.50. The average analyst price target of $5.10 forecasts a 33.86% increase in the stock price over the next year.
Price Target: $5.10 (+33.86%)
Analyst Consensus: Hold
* Price targets were last updated on May 12, 2025.
Analyst Ratings
The average analyst rating for Definitive Healthcare stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 7 | 7 | 7 | 7 | 6 | 6 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold Maintains $3 → $3.4 | Hold | Maintains | $3 → $3.4 | -10.76% | May 12, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $4.5 → $3 | Hold | Maintains | $4.5 → $3 | -21.26% | Mar 4, 2025 |
| Barclays | Barclays | Sell Maintains $4 → $3 | Sell | Maintains | $4 → $3 | -21.26% | Mar 3, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jan 16, 2025 |
| Barclays | Barclays | Hold → Sell Downgrades $4 | Hold → Sell | Downgrades | $4 | +4.99% | Jan 13, 2025 |
Financial Forecast
Revenue This Year
244.15M
from 252.20M
Decreased by -3.19%
Revenue Next Year
248.21M
from 244.15M
Increased by 1.66%
EPS This Year
0.22
from -3.54
EPS Next Year
0.26
from 0.22
Increased by 20.43%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 250.2M | 267.0M | 284.5M |
| Avg | 244.2M | 248.2M | 250.9M |
| Low | 230.0M | 222.4M | 212.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.8% | 9.3% | 14.6% |
| Avg | -3.2% | 1.7% | 1.1% |
| Low | -8.8% | -8.9% | -14.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.24 | 0.40 | 0.47 |
| Avg | 0.22 | 0.26 | 0.26 |
| Low | 0.20 | 0.19 | 0.18 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 82.1% | 79.1% |
| Avg | - | 20.4% | -0.4% |
| Low | - | -15.0% | -33.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.